Seeking Alpha

ATLnsider

 
ABOUT
I am an investor who primarily invests in biotech and pharmaceutical companies. I have over 25 years of financial analylsis and accounting experience.

See Seeking Alpha's policy on anonymous authors.

SNAPSHOT
  • Description: Occasional Investor. Trading frequency: Monthly
  • Interests: Stocks - long, Stocks - short, Tech stocks
COMPANY
Currently, you have no company profile. Click edit to add a company profile.
BLOG
Currently, you have no blog details. Click edit to add blog details.
Book
Currently, you have no book details. Click edit to add book details.
LATEST STOCKTALK more »
Teva To Price Alexza's New Drug ADASUVE At $145 Per Dose In The U.S. $ALXA http://seekingalpha.com/a/16p8v Feb 4, 2014